News & Updates

Show Multimedia Only
Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients

Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients

08 Apr 2022 byNatalia Reoutova

A retrospective study of over 6,000 Chinese patients with acute coronary syndrome (ACS) who underwent first-ever percutaneous coronary intervention (PCI) has shown that use of potent P2Y12 inhibitors, such as ticagrelor and prasugrel, is associated with lower risk of stroke than clopidogrel.

Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients

08 Apr 2022
Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients

Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients

07 Apr 2022 byRoshini Claire Anthony

Nondiabetic adults with overweight or obesity lost more weight when treated with once-weekly semaglutide than once-daily liraglutide, as demonstrated by results of the phase IIIb STEP* 8 trial.

Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients

07 Apr 2022
Psychological intervention plus physiotherapy care most effective for low back pain

Psychological intervention plus physiotherapy care most effective for low back pain

07 Apr 2022
Statins help prevent breast cancer recurrence in Asians

Statins help prevent breast cancer recurrence in Asians

07 Apr 2022 byTristan Manalac

Breast cancer patients who take statins see a sharp decline in the risk of tumour recurrence, according to a recent Singapore study. This protective effect seems to be stronger in ER+ and HER2- malignancies.

Statins help prevent breast cancer recurrence in Asians

07 Apr 2022